FS KKR Capital Corp. enters the week with a persistent tension between a recovering stock price and a mounting short position — the clearest sign yet that bears and bulls are actively disagreeing.
Short interest has rebuilt sharply over the past six weeks. It climbed from roughly 4.2% of the free float in early April to a recent peak of 5.5% on May 11, before easing slightly to 5.3% by May 14. That is a gain of more than 25% in estimated shares short over the period. The one-week change is almost 6%, which means the brief dip this week has not unwound the broader trend. FINRA's official fortnightly print put shares short at 15.66 million as of April 30, giving a days-to-cover reading of 5.4 — not extreme, but not light either.
The borrow picture tells a mixed story. Cost to borrow spiked to 2.37% on May 11 before pulling back to 1.29% by May 14, which is 23% higher than a week prior but actually 15% lower than a month ago. Availability has tightened — the borrow pool is roughly 17% of the way from peak tightness, with the lending market running well below the 52-week tightest levels seen on April 30. Options positioning has shifted more defensive this week. The put/call ratio has climbed to 0.84, nearly two standard deviations above its 20-day average of 0.80, a modest but notable move toward hedging that reinforces the cautious tone from the short side. The ORTEX short score of 59 is broadly consistent with that picture — elevated but not extreme.
The Street has been uniformly cutting targets, and the pace has accelerated. Wells Fargo's Finian O'Shea lowered his target to $10 from $11 on May 12, keeping an Equal-Weight rating. That follows a wave of reductions in March and April: Keefe Bruyette & Woods cut twice (from $18 to $15 in early March, then to $11 in April), RBC trimmed to $13 from $15, and JP Morgan reduced to $9.50 from $13 in March. The mean analyst target now looks stale relative to these recent moves — the consensus cluster of current active targets is bunched in the $9.50-$13 range, all neutral or hold ratings with no active upgrades on the board. Every firm that has touched the name this year has kept the same cautious rating while progressively reducing the price they think the stock is worth. The price-to-book multiple at 0.55x reflects the market's ongoing discount to net asset value, a discount that has widened on the 30-day view.
The bear case centers on NAV erosion: the company reported NAV per share at roughly $21.93 last quarter — well above the current $10.98 stock price — but that figure itself was approximately 6% below prior estimates after realized and unrealized losses. The debt investment portfolio shrank from $14.1 billion to $13.7 billion quarter-on-quarter. Non-accruals rose to 5.3% of portfolio, up from 3.5% the prior quarter. The bull case leans on the BDC's middle-market franchise, a history of managing credit cycles, and the argument that the current leverage ratio remains workable. The most recent earnings print on May 11 produced a modest 0.6% next-day decline — a controlled reaction, not a capitulation.
Insider buying has been consistent but small in dollar terms. The President/CIO Daniel Pietrzak bought 5,000 shares at $11.25 on February 27, alongside an independent director purchase the same day. Those trades came at prices close to current levels, which is notable given that earlier insider buying in November 2025 was done at $15-$15.50 — shares now trade at a meaningful discount to those entries. The pattern suggests insiders are adding rather than exiting, but the absolute dollar sizes are modest, and none of the trades are large enough to signal high conviction.
Close peers confirm that BDC weakness this week is sector-wide. NMFC fell 2.3% on the week, BBDC dropped 3%, and MFIC was the weakest at down 5.7%. FSK outperformed the group, up 1.3% on the week — a relative strength worth watching as the next dividend declaration and any updated NAV guidance approach.
See the live data behind this article on ORTEX.
Open FSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
